ArticleBMJ open2022

Randomised double-blind phase 3 clinical study testing impact of atorvastatin on prostate cancer progression after initiation of androgen deprivation therapy: study protocol.

Aino Siltari et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.